Beta Bionics’ insulin patch pump gets FDA nod
Published . Updated .
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
Directly affected
Indirectly affected
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ASND ASCENDIS PHARMA A/S
GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ATYR ATYR PHARMA INC COM NEW
GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- BBIO BRIDGEBIO PHARMA INC
GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DVA DaVita HealthCare Partners, Inc.
GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- GEHC GE HEALTHCARE TECHNOLOGIES I
GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.
Source: MedTech Dive
The price since 14 Sep 2026: Beta Bionics (BBNX) versus the S&P 500
Since the first closing price after “Beta Bionics’ insulin patch pump gets FDA nod,” Beta Bionics (BBNX) is -12.51%. The S&P 500 fund (SPY) is +1.21% over the same days, a -13.72% difference versus the market.
Official trades in Beta Bionics (BBNX) around 14 Sep 2026
- Gilbert Cisneros sell BridgeBio Pharma (BBIO) ($1,001 - $15,000). That is 15 days after publication, inside 30 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 3 days before publication, inside 30 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 42 days before publication, inside 60 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 46 days before publication, inside 60 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 46 days before publication, inside 60 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 53 days before publication, inside 60 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Rohit Khanna buy GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 55 days before publication, inside 60 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
- Donald J Trump sell GE HealthCare Technologies (GEHC) ($1,001 - $15,000). That is 59 days before publication, inside 60 days. The filing is listed beside the story “Beta Bionics’ insulin patch pump gets FDA nod.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “Beta Bionics’ insulin patch pump gets FDA nod”
Companies tied to this story
- BBNX Beta Bionics
In “Beta Bionics’ insulin patch pump gets FDA nod,” Beta Bionics (BBNX) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names BETA BIONICS INC in the headline; GA resolved that company to BBNX
- ACHC Acadia Healthcare
For “Beta Bionics’ insulin patch pump gets FDA nod,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ASND Ascendis Pharma A/S
In “Beta Bionics’ insulin patch pump gets FDA nod,” Ascendis Pharma A/S (ASND) is linked, with no stored direction, medium confidence. Reason on file: GA selected ASND as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ATYR aTYR PHARMA
aTYR PHARMA (ATYR) is linked, with no stored direction, medium confidence in the 14 Sep 2026 story “Beta Bionics’ insulin patch pump gets FDA nod.” Reason on file: GA selected ATYR as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BBIO BridgeBio Pharma
In “Beta Bionics’ insulin patch pump gets FDA nod,” BridgeBio Pharma (BBIO) is linked, with no stored direction, medium confidence. Reason on file: GA selected BBIO as a RELATED security because its canonical security name directly matches this event's themes: pharma. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DVA Davita
Davita (DVA) is linked, with no stored direction, medium confidence in the 14 Sep 2026 story “Beta Bionics’ insulin patch pump gets FDA nod.” Reason on file: GA selected DVA as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- GEHC GE HealthCare Technologies
GE HealthCare Technologies (GEHC) is linked, with no stored direction, medium confidence in the 14 Sep 2026 story “Beta Bionics’ insulin patch pump gets FDA nod.” Reason on file: GA selected GEHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Beta Bionics’ insulin patch pump gets FDA nod” reaches Beta Bionics (BBNX)
On 14 Sep 2026, “Beta Bionics’ insulin patch pump gets FDA nod” is the story that connects Beta Bionics (BBNX) to this story.
The link for Beta Bionics (BBNX) is this: The reported development directly names BETA BIONICS INC in the headline; GA resolved that company to BBNX
Also listed, Acadia Healthcare (ACHC): GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Beta Bionics (BBNX) price range
ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. ASND traded between 219.69 and 240.84 across 20 sessions. The latest close on file is 229.99. BBNX traded between 16.32 and 23.56 across 20 sessions. The latest close on file is 16.85.
How strong the case is around Beta Bionics (BBNX)
46 out of 100
“Beta Bionics’ insulin patch pump gets FDA nod” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.